These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


182 related items for PubMed ID: 775087

  • 1. Urinary fibrin split products in lupus nephritis.
    Zizic TM, Cwazka WF, Young NS, Stevens MB.
    J Rheumatol; 1976 Mar; 3(1):43-9. PubMed ID: 775087
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The kidney and fibrinolysis. (2) Urinary excretion of FDP].
    Taura K, Fukushima K, Shinzato K, Harada T, Ogata H.
    Nihon Jinzo Gakkai Shi; 1977 Mar; 19(3):139-49. PubMed ID: 560577
    [No Abstract] [Full Text] [Related]

  • 9. [Mechanism of formation and diagnostic value of fibrin fibrinogen split products in kidney allotransplantation].
    Drannik GN.
    Urol Nefrol (Mosk); 1979 Mar; (2):62-9. PubMed ID: 375530
    [No Abstract] [Full Text] [Related]

  • 10. Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases.
    Taira K, Matsunaga T, Kawahara S, Sakamoto S, Kamitsuji H.
    Thromb Res; 1989 Feb 15; 53(4):367-77. PubMed ID: 2929008
    [Abstract] [Full Text] [Related]

  • 11. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects.
    Kim S, Wadhwa NK, Kant KS, Pollak VE, Glas-Greenwalt P, Weiss MA, Hong CG.
    Q J Med; 1988 Nov 15; 69(259):879-905. PubMed ID: 3078212
    [Abstract] [Full Text] [Related]

  • 12. Urinary fibrin split products in lupus nephritis. Correlation with other parameters of renal disease.
    Marchesi SL, Aptekar RG, Steinberg AD, Gralnick HR, Decker JL.
    Arthritis Rheum; 1974 Nov 15; 17(2):158-64. PubMed ID: 4592571
    [No Abstract] [Full Text] [Related]

  • 13. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL, Francis CW, Knutson DW, Marder VJ.
    J Lab Clin Med; 1986 Jun 15; 107(6):534-43. PubMed ID: 3519810
    [Abstract] [Full Text] [Related]

  • 14. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
    Bobkova IN, Kozlovskaia LV, Rameeva AS, Varshavskiĭ VA, Golitsyna EP.
    Ter Arkh; 2007 Jun 15; 79(6):10-5. PubMed ID: 17684960
    [Abstract] [Full Text] [Related]

  • 15. [Clinical significance of lymphocyturia in lupous nephritis].
    Samoĭlova SI.
    Ter Arkh; 1973 May 15; 45(5):55-9. PubMed ID: 4768375
    [No Abstract] [Full Text] [Related]

  • 16. Clinical usefulness of the morphological classification of lupus nephritis.
    Baldwin DS.
    Am J Kidney Dis; 1982 Jul 15; 2(1 Suppl 1):142-9. PubMed ID: 7102664
    [Abstract] [Full Text] [Related]

  • 17. Urinary fibrin degradation products in childhood acute nephritis.
    Dawson KP.
    N Z Med J; 1977 Oct 12; 86(597):332-4. PubMed ID: 272538
    [Abstract] [Full Text] [Related]

  • 18. [Origin of urinary FDP in children with renal diseases].
    Yoshioka K, Iseki T, Ikeda H, Akano N, Uraoka Y, Miyata H, Maki S.
    Nihon Jinzo Gakkai Shi; 1982 Mar 12; 24(3):285-93. PubMed ID: 7120693
    [No Abstract] [Full Text] [Related]

  • 19. Significance of urinary excretion of fibrin degradation products during treatment of glomerulonephritis.
    Michielsen P, Roels L, Vanrenterghem Y, Boel A, van Damme B, Vermylen J.
    Clin Nephrol; 1976 Mar 12; 5(3):105-13. PubMed ID: 1261101
    [Abstract] [Full Text] [Related]

  • 20. [Studies on fibrinolytic therapy in children with various renal diseases with special reference to changes of urinary FDP x D-dimer fragments].
    Kamitsuji H, Iida Y, Omura R, Taira K, Tsukada S, Kusumoto K, Okamoto Y.
    Nihon Jinzo Gakkai Shi; 1982 Nov 12; 24(11):1251-9. PubMed ID: 7166891
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.